Learn more about Chris Boerner, PhD, board chair and chief executive officer at Bristol Myers Squibb. Leading with innovation to deliver vital medicines ...

28 Agu 2024 · Christopher Boerner, age 53, serves as board chair for Bristol Myers Squibb since April 2024 and chief executive officer since November 2023.

1 Nov 2023 · Today Chris Boerner begins his new role as our CEO and on April 1, 2024, he'll succeed Giovanni Caforio as Chair of the Board of Directors.

25 Apr 2024 · Despite layoffs and a hit to earnings, CEO Christopher Boerner was optimistic about the company's prospects in an interview with STAT.

Christopher Boerner is Chief Commercialization Officer of Bristol Myers Squibb, where he leads commercial strategy and execution across all geographies.

By pursuing meaningful work and valuing the people around him, says Chris Boerner, who was recently named board chair and CEO of Bristol Myers Squibb (BMS).

12 Jun 2024 · BMS chief Christopher Boerner says company is still open to deals after spending more than $20B on M&A last year ... As some pharma giants pump ...

17 Nov 2023 · CEO Chris Boerner and SVP Cathi Ahearn, Worldwide Commercial Portfolio Strategy, discussed the importance of gender equity, advocacy and ...

8 Feb 2024 · Chris Boerner, PhD. Chief Executive Officer, Bristol Myers Squibb before the. Committee on Health, Education, Labor, and Pensions. U.S. Senate.

2689 Followers, 1218 Following, 801 Posts - Chris Boerner (@burnoff) on Instagram: "Guitarist, Producer, Mixer, Mastering Engineer"